Sat-05-03-2016, 21:41 PM
(Sat-05-03-2016, 21:33 PM)Grizzly Bear Wrote: Interesting facts though, I would have thought stelera would have been top of the board.
Stelara was the top in my opinion but it looks like getting knocked of by Cosentyx and Ixekizumab in the future. This is only good news for us as the people that make these treatments are going to have to up their game and keep coming up with something to beat their rivals.
Some don't like big Pharma companies, but I'm all for it if it gives me my life back and doesn't cost me. Selfish maybe, but I couldn't afford to pay for it and I've paid my dues so keep them big pharma bio's coming I say I'll take the future treatments any day over the old worn out ones.